By: ChinaBio® Today
August 31, 2013 at 06:13 AM EDT
Week in Review: Simcere Pharma Accepts $495 Million Go-Private Deal
Simcere Pharma’s Board of Directors officially accepted a go-private offer that values the company at $495 million; Xilong Chemical signed a LOI to acquire a 75% interest in Fujian Newland Life Tech for as much as $20 million; Winteam Pharma will sell its 51% stake in Guizhou Zhongtai Biological Technology for $16.5 million; Johnson & Johnson restructured its China operations by putting a single high-powered executive in charge of all three of its China business segments (pharma, devices/diagnostics and consumer health); Siegfried Holdings, a Swiss contract manufacturer, began building a new CMO plant in Nantong; and Siemens Shanghai Medical Equipment completed building a new X-ray machine facility that combines R&D and manufacturing. More details… Stock Symbols: (NYSE: SCR) (SHE: 002584) (HK: 00570) (NYSE: JNJ) (SX: SFZN) (NYSE: SI) Share this with colleagues: // //
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here